TCM
CASC

Tekla Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Tekla Capital Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-740,769
Closed -$2.74M – 196
2017
Q4 		$2.74M Buy
740,769
+286,869
+63% +$1.06M 0.11% 114
2017
Q3 		$1.86M Buy
+453,900
New +$1.86M 0.07% 123